Vote Scores
Filings read through

Kobayashi Pharmaceutical Co., Ltd.: how funds voted at the meeting of 19 Feb 2025

Meeting
Season
year to 30 June 2025
Filers reporting
32
Ballot items
4

32 filers on Form N-PX reported votes at the Kobayashi Pharmaceutical Co., Ltd. meeting of 19 Feb 2025. The records fall into 4 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2025. The latest season on file is the year to 30 June 2026. The page of Kobayashi Pharmaceutical Co., Ltd. has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2025. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections (nominees put forward by security holders)

    3 nominees. 82.7% of the reported votes are for. 7 filers withheld from or voted against at least one nominee.

    142 vote records from 32 filers. 28 of the 31 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 14 fund families
    • For 12
    • Against 2
    • Against management 12
  2. Item 2: Shareholder proposal: CORPORATE GOVERNANCE (A)

    35 vote records from 25 filers. 17 of the 25 filers that marked the item voted against management.

    • Positions of 12 fund families
    • For 10
    • Against 2
    • Against management 10
  3. Item 3: Shareholder proposal: CORPORATE GOVERNANCE (B)

    15 vote records from 7 filers. 1 of the 6 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 2 fund families
    • Against 2
  4. Item 4: Shareholder proposals (not separable from the filings)

    • Proposed by a security holder
    • Several categories

    Filers described these proposals in different words that the site could not match, so they are shown together.

    8 vote records from 2 filers. 0 of the 2 filers that marked the item voted against management.

    • Positions of one fund family
    • Against 1

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Kobayashi Pharmaceutical Co., Ltd., meeting of 19 Feb 2025Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Proposal3. Proposal
BlackRock and iSharesNo reportAgainst
BNY MellonFor, against managementNo report
Charles SchwabNo reportAgainst
DimensionalFor, against managementNo report
EquitableFor, against managementNo report
FidelityFor, against managementNo report
Franklin TempletonFor, against managementNo report
Lincoln FinancialFor, against managementNo report
MFSFor, against managementNo report
Northern Trust and FlexSharesFor, against managementNo report
Nuveen and TIAAFor, against managementNo report
State Street and SPDRAgainstNo report
VanguardAgainstNo report
WisdomTreeFor, against managementNo report

Questions

How many filers reported votes at the Kobayashi Pharmaceutical Co., Ltd. meeting?
32 Form N-PX filers reported votes at the meeting of 19 Feb 2025. The filings show 2 separate proposals from security holders.
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Kobayashi Pharmaceutical Co., Ltd. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Kobayashi Pharmaceutical Co., Ltd. with a meeting date within three days of 19 Feb 2025. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .